Navigation Links
Olympus broadens portfolio with new biliary metallic stent
Date:6/1/2009

CENTER VALLEY, Pa., June 1, 2009 Olympus America Inc. today expanded its medical portfolio by introducing the X-Suit NIR, a biliary metallic stent designed with exceptional anatomic conformability and superior radial support. The X-Suit NIR's proprietary NIRflex cell design provides a physician support and flexibility; both critical to help relieve the symptoms associated with pancreatic, liver and bile duct cancers.

The NIRflex advanced cell design biliary metallic stent provides flexible construction to fit the shape of any biliary duct. Constructed of Nitinol, the stent is water-jet cut and electro-polished for much greater durability. Each strut is also rounded, helping to reduce stress to the tissue and prevent damage to the bile duct and duodenal walls.

"Olympus provides the most extensive line of GI products and services in the industry," said Eric Halvorson, chief marketing officer, Medical Systems Group, Olympus America, Inc. "X-Suit is a good example of how Olympus remains dedicated to expanding its offerings and working with the world's top medical experts to provide solutions that best suit the needs of its customers and their patients."

To ensure precise placement of the stent during a therapeutic procedure, the X-Suit NIR has virtually no foreshortening. In addition, each end of the stent features five radiopaque markers that allow physicians to determine the position of the stent under an X-ray prior to deployment. A black marker is positioned at the proximal end of the stent facilitating endoscopic confirmation of the stent during deployment. The ease of deployment combined with superior radial support makes the X-Suit NIR the stent of choice for re-establishing biliary flow.


'/>"/>

Contact: Lisa Koen
lkoen@golinharris.com
212-373-6099
Golin/Harris International
Source:Eurekalert  

Page: 1

Related biology news :

1. Olympus advances technology for laparo-endoscopic single-site surgery
2. Lockheed Martin Advances Biometrics Portfolio Through Cooperation Agreement With Cognitec
3. Springer expands its portfolio in plant sciences with Phytoparasitica
4. 2 carotid artery stenting studies show results comparable to AHA guidelines
5. Massive California fires consistent with climate change
6. The Lancet publishes first clinical trial data of a fully bioabsorbable drug eluting stent
7. Persistent man-made chemical pollutants found in deep-sea octopods and squids
8. Stent grafts: a better way to treat blunt trauma injuries
9. Goulbourne earns NSF award to research heart stent sensors
10. 12-month ATLANTA trial data show sustained benefit of Catania Stent
11. Persistent pollutant may promote obesity
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Olympus broadens portfolio with new biliary metallic stent
(Date:6/16/2016)... , June 16, 2016 ... is expected to reach USD 1.83 billion by ... View Research, Inc. Technological proliferation and increasing demand ... are expected to drive the market growth. ... The development of advanced multimodal techniques ...
(Date:6/9/2016)... 2016 Paris Police Prefecture ... security solution to ensure the safety of people and operations ... the major tournament Teleste, an international technology group ... announced today that its video security solution will be utilised ... up public safety across the country. The system roll-out is ...
(Date:6/2/2016)... LONDON , June 2, 2016 ... has awarded the 44 million US Dollar project, ... Security Embossed Vehicle Plates including Personalization, Enrolment, and IT Infrastructure ... world leader in the production and implementation of Identity Management ... in January, however Decatur was selected ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... 2016  Blueprint Bio, a company dedicated to identifying, ... community, has closed its Series A funding round, according ... "We have received a commitment from Forentis Fund ... to meet our current goals," stated Matthew Nunez ... to complete validation on the current projects in our ...
(Date:6/23/2016)... On Wednesday, June 22, 2016, the NASDAQ Composite ... Jones Industrial Average edged 0.27% lower to finish at 17,780.83; ... has initiated coverage on the following equities: Infinity Pharmaceuticals Inc. ... NKTR ), Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ ), ... more about these stocks by accessing their free trade alerts ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... and technical consulting, provides a free webinar on Performing Quality Investigations: ... 2016 at 12pm CT at no charge. , Incomplete investigations are still a ...
Breaking Biology Technology: